Commercial launch of BIOCERA-VET® COMBO-CLEAN, new product reference, in May
Initiation of 3 programs in high value-added markets (Osteosarcoma, Equine and Non-Union)
Dense program of scientific and clinical actions at key events in Europe and the United States
Gosselies (Wallonia, Belgium), July 11, 2023 – 07:30 CEST — TheraVet (ISIN code: BE0974387194 – mnemonic: ALVET), a pioneering biotechnology company in the management of osteoarticular diseases in companion animals, provides a half-year update on its development strategy.
To receive all of TheraVet’s financial information in real time, send a request by email to [email protected]